Anti-Obesity Therapeutics Market Professional Survey Report 2019

vihag thakur

Anti-obesity drugs are the drugs that help in reducing or controlling body mass, either by decreasing the craving or increasing the consumption of calories. Appetite control is achieved through the use of agonists for appetite suppressing pathways.

Geographically, North America captures the largest market share on account of increasing obese population. As per the historical trends, more than one-third of the U.S. population is obese. However, Asia Pacific is anticipated to grow at the fastest rate due to increasing demand for the drugs and awareness about the risk associated with obesity. According to WHO, 13.0% of the population were obese in 2014. In developing countries the rate of childhood obesity is increasing and has been 30.0% higher than that of developed countries.

Report Sample includes:
- Table of Contents
- List of Tables & Figures
- Charts
- Research Methodology

Get FREE Sample of this Report at https://www.24marketreports.com/report-sample/global-antiobesity-therapeutics-2019-851

The global Anti-Obesity Therapeutics market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019–2025.

This report focuses on Anti-Obesity Therapeutics volume and value at global level, regional level and company level. From a global perspective, this report represents overall Anti-Obesity Therapeutics market size by analyzing historical data and future prospect.

Regionally, this report categorizes the production, apparent consumption, export and import of Anti-Obesity Therapeutics in North America, Europe, China, Japan, Southeast Asia and India.

For each manufacturer covered, this report analyzes their Anti-Obesity Therapeutics manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:

  • Bristol-Myers Squibb
  • Eisai Company
  • FlaxoSithKline plc.
  • Novo Nordisk
  • Alizyme
  • BoehringerIngelheim GmbH
  • Pfizer
  • Takeda Pharmaceutical
  • Rhythm Pharmaceuticals
  • Shionogi USA
  • Vivus
  • Zafgen
  • Norgine Pharmaceuticals Ltd.

Segment by Regions

  • North America
  • Europe
  • China
  • Japan
  • Southeast Asia
  • India

Segment by Type

  • Centrally Acting Anti-obesity Drugs
  • Peripherally Acting Anti-obesity Drugs

Segment by Application

  • Hospital Use
  • Clinic Use
  • Household
  • Other

Get the Complete Report & TOC at https://www.24marketreports.com/life-sciences/global-antiobesity-therapeutics-2019-851

276 5th Avenue, New York , NY 10001,United States
International: (+1) 646 781 7170
Email: [email protected]

Follow Us On linkedin :- https://www.linkedin.com/company/24-market-reports

vihag thakur
Zupyak is a free content platform for publishing and discovering stories, software and startups.